Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objective of this study is - to estimate the clinical benefit of Vismodegib given as therapy for patients with locally advanced or metastatic BCC, as measured by overall response rate (ORR).
Critère d'inclusion
- • metastatic BCC with histologic confirmation of a distant BCC metastasis (e.g., lung, liver, lymph nodes, or bone)
- • locally advanced BCC considered inoperable or with medical contraindication to surgery
- • nevoid BCC syndrome (Gorlin syndrome), meeting the criteria for locally advanced or metastatic disease